Cargando…

Methodological Issues in Using a Common Data Model of COVID-19 Vaccine Uptake and Important Adverse Events of Interest: Feasibility Study of Data and Connectivity COVID-19 Vaccines Pharmacovigilance in the United Kingdom

BACKGROUND: The Data and Connectivity COVID-19 Vaccines Pharmacovigilance (DaC-VaP) UK-wide collaboration was created to monitor vaccine uptake and effectiveness and provide pharmacovigilance using routine clinical and administrative data. To monitor these, pooled analyses may be needed. However, va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delanerolle, Gayathri, Williams, Robert, Stipancic, Ana, Byford, Rachel, Forbes, Anna, Tsang, Ruby S M, Anand, Sneha N, Bradley, Declan, Murphy, Siobhán, Akbari, Ashley, Bedston, Stuart, Lyons, Ronan A, Owen, Rhiannon, Torabi, Fatemeh, Beggs, Jillian, Chuter, Antony, Balharry, Dominique, Joy, Mark, Sheikh, Aziz, Hobbs, F D Richard, de Lusignan, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400842/ https://www.ncbi.nlm.nih.gov/pubmed/35786634 http://dx.doi.org/10.2196/37821

Ejemplares similares

Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study
por: Tsang, Ruby SM, et al.
Publicado: (2023)

COVID-19 vaccine uptake, effectiveness, and waning in 82,959 health care workers: A national prospective cohort study in Wales
por: Bedston, Stuart, et al.
Publicado: (2022)

COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: A national prospective cohort study
por: Bedston, Stuart, et al.
Publicado: (2023)

Investigating the uptake, effectiveness and safety of COVID-19 vaccines: protocol for an observational study using linked UK national data
por: Vasileiou, Eleftheria, et al.
Publicado: (2022)

Anaphylactic Reactions to COVID-19 Vaccines: An Updated Assessment Based on Pharmacovigilance Data
por: Boufidou, Fotini, et al.
Publicado: (2023)

Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study
por: Vasileiou, Eleftheria, et al.
Publicado: (2021)

Investigating the association between COVID-19 vaccination and care home outbreak frequency and duration
por: Bradley, D.T., et al.
Publicado: (2022)

Risk of thrombocytopenic, haemorrhagic and thromboembolic disorders following COVID-19 vaccination and positive test: a self-controlled case series analysis in Wales
por: Torabi, Fatemeh, et al.
Publicado: (2022)

Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance
por: Ruggiero, Rosanna, et al.
Publicado: (2022)

Developing a Long COVID Phenotype for Postacute COVID-19 in a National Primary Care Sentinel Cohort: Observational Retrospective Database Analysis
por: Mayor, Nikhil, et al.
Publicado: (2022)

Using the COM-B framework to elucidate facilitators and barriers to COVID-19 vaccine uptake in pregnant women: a qualitative study
por: Patterson, Lynsey, et al.
Publicado: (2023)

Pharmacovigilance in vaccines
por: Budhiraja, Salil, et al.
Publicado: (2010)

Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales
por: Kerr, Steven, et al.
Publicado: (2022)

Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales
por: Agrawal, Utkarsh, et al.
Publicado: (2022)

First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland
por: Simpson, C. R., et al.
Publicado: (2021)

French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge
por: Lacroix, Clémence, et al.
Publicado: (2021)

COVID-19 VACCINES AND ATRIAL FIBRILLATION RISK: A PHARMACOVIGILANCE ANALYSIS
por: Kattubadi, Ayeesha, et al.
Publicado: (2022)

Pharmacovigilance for COVID-19 vaccines: A 1-year experience in France
por: Crommelynck, S., et al.
Publicado: (2022)

A Call to Enhance Active and Transparent Pharmacovigilance for COVID-19 Vaccines
por: Kunene, Khontile Nobuhle, et al.
Publicado: (2023)

First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales
por: Kerr, Steven, et al.
Publicado: (2022)

Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb: One Year of COVID-19 Vaccine Experience
por: Oosterhuis, Ingrid, et al.
Publicado: (2022)

COVID-19 vaccine uptake and effectiveness in adults aged 50 years and older in Wales UK: a 1.2m population data-linkage cohort approach
por: Perry, Malorie, et al.
Publicado: (2022)

Global safety monitoring of COVID-19 vaccines: how pharmacovigilance rose to the challenge
por: Rudolph, Annette, et al.
Publicado: (2022)

COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study
por: Ferrara, Francesco, et al.
Publicado: (2022)

Inequalities in coverage of COVID-19 vaccination: A population register based cross-sectional study in Wales, UK
por: Perry, Malorie, et al.
Publicado: (2021)

Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems
por: Shrestha, Sunil, et al.
Publicado: (2021)

Beyond the jab: A need for global coordination of pharmacovigilance for COVID-19 vaccine deployment
por: Naniche, Denise, et al.
Publicado: (2021)

Cluster headache after COVID-19 vaccination with Comirnaty: A signal in pharmacovigilance database()
por: Rochoy, Michaël, et al.
Publicado: (2022)

COVID-19 Vaccines Adverse Reactions Reported to the Pharmacovigilance Unit of Beira Interior in Portugal
por: Amaro, Carina, et al.
Publicado: (2022)

COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database
por: Ruggiero, Rosanna, et al.
Publicado: (2023)

Role of Pharmacovigilance on Vaccines Control*
por: Kuçuku, Merita
Publicado: (2012)

COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study
por: Agrawal, Utkarsh, et al.
Publicado: (2021)

Evaluation of the safety profile of rotavirus vaccines: a pharmacovigilance analysis on American and European data
por: Bonaldo, Giulia, et al.
Publicado: (2020)

Evolving pharmacovigilance requirements with novel vaccines and vaccine components
por: Zuber, Patrick L F, et al.
Publicado: (2021)

Data mining methodology for response to hypertension symptomology—application to COVID-19-related pharmacovigilance
por: Xu, Xuan, et al.
Publicado: (2021)

COVID-19 vaccine data provide reassurance
por: The Lancet Rheumatology
Publicado: (2021)

Big data analytics and COVID-19 vaccine
por: Aslam, Fahmida, et al.
Publicado: (2022)

Assessing the Clinical and Socioeconomic Burden of Respiratory Syncytial Virus in Children Aged Under 5 Years in Primary Care: Protocol for a Prospective Cohort Study in England and Report on the Adaptations of the Study to the COVID-19 Pandemic
por: Hoang, Uy, et al.
Publicado: (2022)

Need of Vibrant Vaccine Pharmacovigilance During Current Global COVID-19 Pandemic: More Than Ever
por: Meher, Bikash Ranjan
Publicado: (2021)

Trends in reporting embolic and thrombotic events after COVID-19 vaccination: A retrospective, pharmacovigilance study
por: Kan, Yusuke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pcpnt0i0dmg4b5ubq9n290tu85